Veeva Systems (NYSE:VEEV – Get Free Report) and Nyxoah (NASDAQ:NYXH – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, risk, profitability, earnings, institutional ownership, valuation and dividends.
Earnings and Valuation
This table compares Veeva Systems and Nyxoah”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Veeva Systems | $3.20 billion | 10.08 | $714.14 million | $5.41 | 36.21 |
| Nyxoah | $4.89 million | 26.05 | -$64.10 million | ($2.49) | -1.50 |
Profitability
This table compares Veeva Systems and Nyxoah’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Veeva Systems | 28.44% | 14.11% | 11.76% |
| Nyxoah | -1,457.97% | -101.99% | -66.74% |
Volatility & Risk
Veeva Systems has a beta of 1.09, meaning that its stock price is 9% more volatile than the S&P 500. Comparatively, Nyxoah has a beta of 1.56, meaning that its stock price is 56% more volatile than the S&P 500.
Analyst Recommendations
This is a breakdown of recent ratings and target prices for Veeva Systems and Nyxoah, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Veeva Systems | 1 | 7 | 17 | 0 | 2.64 |
| Nyxoah | 1 | 0 | 3 | 1 | 2.80 |
Veeva Systems currently has a consensus price target of $284.91, suggesting a potential upside of 45.45%. Nyxoah has a consensus price target of $11.67, suggesting a potential upside of 211.94%. Given Nyxoah’s stronger consensus rating and higher probable upside, analysts plainly believe Nyxoah is more favorable than Veeva Systems.
Insider and Institutional Ownership
88.2% of Veeva Systems shares are held by institutional investors. 10.3% of Veeva Systems shares are held by company insiders. Comparatively, 17.1% of Nyxoah shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Summary
Veeva Systems beats Nyxoah on 9 of the 15 factors compared between the two stocks.
About Veeva Systems
Veeva Systems Inc. provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States. The company also provides Veeva Development Cloud, a suite of applications for the clinical, regulatory, quality, and safety functions, including Veeva Vault Clinical, Veeva Vault RIM, Veeva Vault Safety, and Veeva Vault Quality; Veeva QualityOne, a quality and document management, and training solution; Veeva RegulatoryOne, a solution that helps companies to manage regulatory submission content; and Veeva Claims addresses the end-to-end product and marketing claims management process. In addition, it offers professional and support services, including implementation and deployment planning and project management; requirements analysis, solution design, and configuration; systems environment management and deployment services; services focused on advancing or transforming business and operating processes related to Veeva solutions; data migration and systems integrations technical consulting services; training on its solutions; and ongoing managed services, such as outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.
About Nyxoah
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.
